OLIGONUCLEOTID TABLETS: Process to formulate oligonucleotids into tablets for an oral administration

APPLICATIONS

• New galenic formulation for therapeutic approach based on oligonucleotids
• Tablets suitable for siRNA, shRNA, miRNA, mRNA and RNAi
• Oral administration of biological active molecules

DESCRIPTION

• Patented process to compress into tablets the oligonucleotids while maintaining their therapeutic activity
• Compatible with large panel of encapsulated vectors
• Possibility to combine the approach with the well known process to control the delivery
• Combination of multiple therapeutic oligonucleotids in a single tablet

BENEFITS

• Opens new perspectives for simple use of therapeutic oligonucleotids
• Obtention of sterilized, stable, easy to store tablets
• High patient compliance expected